Global Lipopolysaccharides Immunoassay Market Product, Services And Solutions Analysis 2022

Posted by sandeep gade on November 16th, 2022

The lipopolysaccharides immunoassay market was worth US$ 1.3 Bn at the end of 2021 and is expected to increase at a CAGR of 3.2% over the forecast period (2022-2032).

The growing threat of infection proliferation and spread, as well the emergence of a pandemic has proposed a great need for lipopolysaccharides immunoassay kits and reagents. Early detection of zoonotic disease spread is beneficial to community health and overall wellness.

Although the occurrence of a natural infection is relatively infrequent in humans, yet, diseases such as tularaemia pose a severe potential hazard to public health due to their persistence in water supplies, arthropod vectors, and animal reservoirs, as well as their low degree of clinical detection. PCR, serological assays, and bacterial culture of patient samples are some of the current diagnostic methods; however, these methods take time and call for technical knowledge that might not be readily available at the point of care. A more sensitive diagnostic platform is necessary in the event of an outbreak or exposure.

Growing adoption of lipopolysaccharides immunoassay kits for the detection of such potentially lethal zoonotic diseases caused by intracellular gram-negative bacteria will provide a boost to the growth of the lipopolysaccharides immunoassay market over the years.

Moreover, with the need for analytical technology on the rise, the development of immunoassay test kits is expected to surge due to growing awareness among the general population in terms of infection prevention and control.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the lipopolysaccharides immunoassay market in its latest study, presenting a historical demand assessment of 2012 – 2021 and projections for 2022 – 2032.

The research study is based on the product type (immunoassay kits & reagents [kits, primary antibodies, secondary antibodies, immunoassay substrates, and immunoassay buffers], analysers & instruments, consumables, and software), assay (ELISA, FIA, CLIA, LFA, and others), purpose (research use only and clinical use), application (clinical diagnostics, drug discovery, and screening of diseases & disorders), and end user (biopharmaceutical companies, contract manufacturing organizations, contract research organizations, and research & academic institutes), across seven key regions of the world.

Buy Full Report Now and Get Up to 20% Discount: https://www.persistencemarketresearch.com/checkout/33143